Carbon black is not acutely toxic at typical exposure levels, but it can cause harm over time, particularly when inhaled. The International Agency for Research on Cancer (IARC) classifies it as “possibly carcinogenic to humans” (Group 2B), based on strong animal evidence and limited human data. The real risk depends heavily on how you’re exposed, how much, and for how long.
What Carbon Black Is and Where You Encounter It
Carbon black is a fine black powder made by burning petroleum products in low-oxygen conditions. It’s mostly elemental carbon, but it can carry trace amounts of harmful compounds called polycyclic aromatic hydrocarbons (PAHs), which form during production. It shows up in a surprising range of products: tires, rubber goods, inks, paints, plastics, and some cosmetics. If you’re searching this question, you likely encountered it on an ingredient list or work with it in an industrial setting.
There are two broad grades of commercial carbon black based on chemical purity. Cleaner grades contain roughly 200 to 400 micrograms of extractable compounds per gram, while higher-impurity grades carry 1,000 to 2,000 micrograms per gram. The PAHs in carbon black are tightly bound to the particle surface, which limits how readily they leach into your body. But the particles themselves, independent of any chemical hitchhikers, cause biological damage when they reach your lungs.
Why Particle Size Matters
Carbon black particles range from nanoscale (under 100 nanometers) to micron-sized. That size difference has a dramatic effect on toxicity. Nanoparticles have vastly more surface area per unit of weight, which means more of the particle is available to interact with your cells. Lab studies on human immune cells show that nano-sized carbon black causes significantly greater cell death, stronger inflammatory responses, and higher release of inflammatory signaling molecules than the same weight of larger particles.
Nano-sized carbon black also disrupts the ability of immune cells to engulf and clear foreign material, a function called phagocytosis. Larger, micron-sized particles did not impair this function at any concentration tested. This matters because when your lungs can’t clear particles efficiently, those particles accumulate and cause ongoing damage. The toxicity is both size-dependent and dose-dependent: smaller particles at higher concentrations do the most harm.
How Inhalation Damages Your Lungs
The lungs are the primary target. When carbon black particles are inhaled, they trigger a cascade of inflammation. Immune cells, mainly macrophages and neutrophils, flood into the airways and the tiny air sacs where gas exchange happens. The tissue lining the airways begins to overgrow (a process called epithelial hyperplasia), and the lungs produce elevated levels of inflammatory signaling molecules, particularly one called IL-6 that activates neutrophils and amplifies the immune response.
At the same time, exposure increases production of a protein called fibronectin, which is a marker of early scarring in lung tissue. Fibronectin accumulates during the inflammatory phase and signals that the lung is moving toward fibrosis, a condition where normal, flexible tissue is replaced by stiff scar tissue. Compounding this, carbon black exposure suppresses a protective molecule that normally limits scar formation by keeping fibroblasts (scar-producing cells) in check. The result is a lung environment primed for chronic damage: more inflammation, less repair, and progressive scarring with continued exposure.
The particles also generate reactive oxygen species, essentially unstable molecules that damage DNA and cell membranes. Over time, this oxidative stress and the resulting cycle of cell injury and repair can lead to mutations. This is the pathway most strongly supported by experimental evidence for how carbon black might eventually cause cancer in lung tissue.
The Cancer Question
IARC’s Group 2B classification means “possibly carcinogenic to humans,” which is a middle-tier designation. The evidence behind it splits clearly between animals and humans. In animal studies, the case is strong: six separate studies in rats found significant increases in malignant lung tumors after inhalation or direct delivery of carbon black to the lungs. Additional studies found skin tumors when solvent extracts of carbon black were applied to rat skin, and sarcomas when injected under the skin of mice.
Human evidence is far less clear. A large cohort study of U.S. carbon black production workers, with 96% follow-up completion, found no excess lung cancer risk (the standardized mortality ratio was 0.97, essentially identical to the general population). All-cause and all-cancer mortality were actually lower than expected. No trends appeared with longer employment or more years since first hire. Two other studies of carbon black workers did observe some excess lung cancer risk, but the overall body of human evidence was judged inadequate to confirm that carbon black causes cancer in people.
The gap between animal and human findings likely reflects dose differences. Rats in laboratory studies are exposed to concentrations high enough to overwhelm their lung clearance mechanisms, creating a condition called “lung overload” that may not occur in workers exposed at regulated levels. Still, the animal mechanism is biologically plausible and well-documented, which is why the classification sits at “possibly” rather than “probably” or “not classifiable.”
Workplace Exposure Limits
OSHA sets the permissible exposure limit for carbon black at 3.5 mg/m³ of air, measured as an 8-hour time-weighted average. This applies to carbon black without significant PAH contamination. When PAHs are present, NIOSH treats carbon black as a potential occupational carcinogen, which triggers stricter controls and monitoring. At or below 3.5 mg/m³, the PAH content of commercial carbon black is considered too low and too tightly bound to the particles to pose a carcinogenic risk from that route alone.
Workers in carbon black production, tire manufacturing, printing, and rubber compounding face the highest exposure levels. Proper ventilation, respiratory protection, and dust suppression are the main tools for keeping exposure within safe limits.
Skin Contact and Consumer Products
The connection between soot exposure and skin cancer dates back to 1775, when a London surgeon named Percival Pott noticed that chimney sweeps developed scrotal cancer at unusually high rates. Later research identified workers in the tire and rubber industry as having elevated skin cancer risk linked to carbon black exposure. However, modern commercial carbon black appears to carry less carcinogenic potential than environmental soot, which contains a more complex and concentrated mixture of harmful compounds.
In consumer products, carbon black’s regulatory status is restrictive. The FDA delisted carbon black as a color additive for food, drugs, and cosmetics in 1976. It is not approved for use near the eyes, in injections, or in surgical materials. Despite the delisting, carbon black still appears in some cosmetic products in certain markets. If you’re seeing it on an ingredient label, it is functioning as a pigment, and dermal exposure at the concentrations found in consumer products is generally considered low risk compared to chronic inhalation in industrial settings.
Environmental Toxicity
Carbon black is not particularly toxic to aquatic life. Testing on zebrafish showed a lethal concentration (the dose that kills half the test population in 96 hours) above 1,000 mg per liter. For water fleas, the threshold was above 5,600 mg per liter, and for algae, above 10,000 mg per liter. These are extremely high concentrations, meaning carbon black is unlikely to cause acute harm to aquatic ecosystems at realistic environmental levels. The concern with carbon black in the environment is more about its persistence as an insoluble particulate than about direct chemical toxicity to organisms.